Find and compare companies providing Drug Substance (CDMO/CRO) services for:
Intermediates
Filters
Production region
Production scale
Qualifications
CDMO-CRO
Plants in:
Established in: 1886
Production scale:
medium
small
Employees: 275+

Raw materials, CMO and OTC products

Two GMP certified locations

Customisable (small-sized) packages
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 2008
Production scale:
large
small
medium
Employees: 4.000

With 14 production sites in Europe and the USA

7 Development Centers of Excellence covering all dosage forms

13 locations with Technology Services on site for seamless Tech Transfer and product Life-Cycle Management
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1993
Production scale:
small
medium
large
Employees: 600

Integrated innovative platforms for Technology Transfer (TT&GO®)

Fermentation, purification, and chemical synthesis technologies on the same site

Scalability from Laboratory and Pilot to Industrial scales
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1997
Production scale:
small
medium
Employees: 140

Top-tier adherence to global pharmaceutical standards including GMP, FDA and EMA

Specialized advanced chemistry laboratory focused on upscaling and GMP transfer processes

Comprehensive analytical services to meet precise client specifications.
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 2012
Production scale:
medium
Employees: 180

A high-tech enterprise with 13 own patents granted

Strong R&D system with ISO9001 / ISO14001 / OHSAS18001 certification

Provide professional CMO & CDMO service
All certificates
Replies quickly
Plants in:
Established in: 1982
Production scale:
small
Employees: 30+

Modern GMP facility

Team of academics and technical experts

Small to large batch sizes possible
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 2013
Production scale:
medium
Employees: 25+

ISO9001 certified

Drug R&D center (in Hangzhou)

From lab scale (mg/g) to commercial scale (kgs/tons)
All certificates
Replies quickly
Plants in:
Established in: 2014
Production scale:
small
medium
large
Employees: 1000+

24 years of production experience

6 workshops and 9 production lines which has 100t/month production capacity

4 USDMFS & 8 CEPS & 200+ Patents
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1987
Production scale:
medium
small
large
Employees: 50+

ISO 9001:2015 & SGS audited supplier

One-stop CDMO Solutions for APl and Key intermediates

Specialized in APIs & Pharmaceutical Intermediates for 38 years
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 2022
Production scale:
large
Employees: 50

Complex Chemistry Expertise – 30+ advanced chemistries backed by a strong R&D team

End-to-End Molecule Development from Idea to Commercial Scale

Global Quality, India Advantage – cGMP/FDA-compliant facilities, world-class SHE & IP standard at effecient pricing
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 2006
Production scale:
small
medium
Employees: 20

Quality Assurance: Products are manufactured from the finest raw materials and undergo rigorous testing.

Tailored Customisation & Compliance: Providing end-to-end solutions to meet your business

Dependable Expertise and Supply: Backed by years of industry experience and a robust supply chain.
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1965
Production scale:
small
medium
large
Employees: 600+

Pharmaceutical-quality dextrans meeting the highest standards and complying with major pharmacopeias

Manufactured in a cGMP facility in Denmark, inspected by both the FDA and EMA

Documented quality and certifications from the US FDA and EDQM for smooth regulatory submission
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 2003
Production scale:
large
Employees: 4000+

20+ years’ expertise in API manufacturing, trusted for quality and global compliance.

Listed pharma leader in China, prioritizing transparency and regulatory excellence.

End-to-end integration from R&D to scalable production, delivering cost-efficient solutions.
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1951
Production scale:
medium
Employees: 455+

Largest Polish manufacturer of pharmaceuticals and a leader of the Polish pharmaceutical market.

FDA approved european manufcaturing facilities

Export APIs to more than 60 countries worldwide
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1989
Production scale:
large
Employees: 5000+

6 production facilities approved by USFDA, AGES-Austria, PMDA, WHO

R&D Centers with capabilities of ANDAs, DMFs and NDDS

462+ patents filed for drug substances and polymorphs
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 2006
Production scale:
small
medium
large
Employees: 3500

Silver EcoVadis awardee committed to sustainability

Exceptional synthesis experience of HPAPIs

One-stop CDMO Solutions for APl and Key intermediates
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1964
Production scale:
small
medium
large
Employees: 135+

Market leader in Switzerland

Small and medium batch sizes

Pharmaceutical raw materials with a herbal or synthetic basis
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1952
Production scale:
small
medium
large
Employees: 550+

API manufacturing (Innovators, Generics and Highly Potent)

A tailor-made and flexible service approach

State-of-the-art analytical services including solid form and QbD laboratories
All certificates
Replies quickly
Plants in:
Established in: 2008
Production scale:
large
medium
Employees: 300+

More than 150 patents based on independent intelligence

Expertise in anti-tumor, anti-diabetes and cardiovascular API and intermediates.

GMP facility with annual production capacity of 300M
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 2021
Production scale:
small
Employees: 19

API, Intermediates, Building Blocks, Impurities, Amino acids and Peptides

Small quantity APIs to commercial scale

GMP and USFDA certification based on quantity, order, assignment.
All certificates
Replies quickly
Plants in:
Established in: 2016
Production scale:
small
medium
large
Employees: 200

PFAS-Free Peptides

Certified Quality & Sustainability with ISO 9000 certification and RSPO audited supplier & GMP

Specialized in APIs & Pharmaceutical Intermediates
All certificates
Replies quickly
Looking for Drug Substance (CDMO/CRO) Services?
Find a list of providers specializing in CMOs/CDMOs Services for Intermediates. Navigate through our extensive selection to identify the supplier that aligns with your specific needs.
Pharmaoffer makes it easy and convenient to send inquiries at no cost. Directly connect with your chosen supplier and take the first step towards fulfilling your pharmaceutical needs easily and efficiently.
Drug Substance (CDMO/CRO)
Drug Substance CDMOs and CROs provide end-to-end solutions for pharmaceutical companies developing and manufacturing active pharmaceutical ingredients (APIs). These organizations offer critical support in R&D, process development, scale-up, and GMP manufacturing, enabling pharma and biotech companies to accelerate time-to-market while ensuring compliance with global regulatory standards.
Intermediates
Intermediates outsourcing focuses on producing key starting materials and intermediate compounds used in the API synthesis pathway.
A pharmaceutical CDMO can develop and scale intermediate steps, then deliver materials with controlled specifications for downstream API production.
Typical steps include route optimization, scale-up, impurity control, and supply planning.
Key constraints often involve raw material sourcing, hazardous chemistry, and consistent quality across campaigns.
Practical answers for buyers sourcing CDMO services for intermediates manufacturing.
An intermediates CDMO manufactures key starting materials and intermediate compounds used in API synthesis.
Services include process development, scale-up, and GMP or non-GMP production depending on program needs.
Intermediates are upstream compounds used before the final API step.
They require controlled specifications but may have different GMP expectations based on regulatory strategy.
Include route step details, desired specifications, batch size, and target markets.
Provide any impurity concerns, safety hazards, and supply timelines.
Some do, while others specialize in non-GMP or early-stage intermediates.
Clarify GMP requirements and documentation needs in your RFQ.
Confirm analytical methods, impurity profiles, and batch consistency.
Ensure traceability to raw materials and robust change control practices.
Scale can range from kilogram to multi-ton campaigns depending on stage.
Provide demand forecasts to align capacity and scheduling.
Many CDMOs support hazardous chemistry with containment and safety controls.
Ask about reactor capabilities, safety reviews, and solvent handling.
Confirm lead times, dual sourcing options, and inventory strategies.
A strong CDMO will provide risk mitigation plans for critical materials.
Pitfalls include unclear specifications, late changes to route steps, and underestimating impurity carryover.
Early alignment on quality targets helps avoid rework.
Yes, many provide tech transfer support with process documentation and scale-up data.
Share lab-scale parameters to reduce variability.
Analytical capabilities are critical for confirming identity and impurity levels.
In-house QC can shorten turnaround times and improve batch release speed.
Documentation requirements depend on how the intermediate fits into the API filing.
Clarify the level of GMP documentation and traceability needed.
Yes, many provide custom synthesis and route optimization for specific intermediates.
Validate experience with similar chemistry and scale.
Filter by region, stage, and services, then compare chemistry experience and capacity.
Shortlist partners with strong quality systems and supply reliability.
What is intermediates outsourcing (CDMO)?
When to choose a CDMO for intermediates
Common buyer requirements
Intermediates CDMO services FAQ
What does an intermediates CDMO do?
How are intermediates different from APIs?
What should I include in an intermediates CDMO RFQ?
Do intermediates CDMOs provide GMP manufacturing?
How do I evaluate quality for intermediates outsourcing?
What are typical scale ranges for intermediates manufacturing?
Can intermediates CDMO services support hazardous chemistry?
How do I manage supply chain risk for intermediates?
What are common pitfalls in intermediates CDMO outsourcing?
Do intermediates CDMOs support tech transfer?
How important are analytical capabilities for intermediates?
Do intermediates require regulatory documentation?
Can intermediates CDMO services include custom synthesis?
How do I shortlist intermediates CDMO companies in this directory?






















